Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes [NA]

View source ↗

Summary

This clinical trial investigates how hepatic triglyceride biosynthesis varies across insulin resistance phenotypes in people with hypertriglyceridemia, aiming t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Insulin Resistance, Hypertriglyceridemia | NA | Status: RECRUITING